Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Interest Expenses (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Interest Expenses for 6 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 2.74% year-over-year to $1.3 million, compared with a TTM value of $5.3 million through Dec 2025, up 1.22%, and an annual FY2025 reading of $5.3 million, up 1.22% over the prior year.
  • Interest Expenses was $1.3 million for Q4 2025 at Treace Medical Concepts, up from $1.3 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.3 million in Q4 2025 and bottomed at $946000.0 in Q2 2022.
  • Average Interest Expenses over 5 years is $1.2 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Interest Expenses skyrocketed 133.79% in 2021, then fell 8.86% in 2022.
  • Year by year, Interest Expenses stood at $1.0 million in 2021, then grew by 27.53% to $1.3 million in 2022, then dropped by 0.53% to $1.3 million in 2023, then grew by 0.77% to $1.3 million in 2024, then grew by 2.74% to $1.3 million in 2025.
  • Business Quant data shows Interest Expenses for TMCI at $1.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.3 million in Q2 2025.